Please browse our latest news, for information from around the firm and updates on our recent work.
Charles Russell Speechlys Hong Kong successfully defends equal opportunities action brought against Novartis
We have successfully defended NYSE-listed healthcare company Novartis against an equal opportunities action filed by a former employee.
Charles Russell Speechlys advises Apposite Capital on acquisition of i2a Diagnostics
i2a is a leading provider of laboratory instruments, software and reagents for the clinical microbiology market in France.